Introducing the Xevo TQ Absolute IVD mass spectrometer
Waters launches a highly sensitive and compact clinical IVD system
Waters launches a highly sensitive and compact clinical IVD system
The partnership hopes to bolster the effort to provide commerical-grade cell and gene therapy solutions
Its investment includes a new manufacturing facility in Europe
Join us Wednesday, November 18, to discover the impact metal interactions have on oligo analysis
Join this webinar to learn about the potential of computer-assisted interpretation and linking disease markers identified by NMR to the metagene database
Exploring microbiome-directed therapies, precision medicine with big data, health equity, and more
Simplified, standardized, and accelerated sample preparation for discovery and translational research
We’ve highlighted lab product reviews of drug discovery lab solutions that could benefit your workflows and research
Companies will showcase combined solution at American Association for Cancer Research (AACR) Annual Meeting 2022
Increased levels of blood fats in people with type 2 diabetes and obesity are more harmful than previously thought, a new study has found
The company expands into key market verticals in diagnostics, therapeutics, and research discovery with solutions for proteins, genomics, and diagnostic assay development services
Discover the latest tools and techniques to expand your research capacity with expert-led presentations on in situ material testing, plastic materials, and proteomics
Researchers reporting in ACS have developed an ultrasensitive tongue which can measure sweetness by mimicking taste buds
Funding of $231.8 million U.S. awarded to Ellume COVID-19 Home Test that integrates AnteoBind™ for superior sensitivity
The high-throughput system enables laboratories to double or even triple their testing capacity
This powerful new solution aims to provide more accurate COVID-19 antibody detection
New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies and can guide treatment decisions for patients with Lynch-associated cancers